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ABSTRACT
Background: Myocardial injury after noncardiac surgery is considered a common perioperative
complication associated with increased morbidity and mortality following surgery. Patients who
sustain MINS are predominantly asymptomatic and do not meet the conventional definition and
diagnostic criteria for myocardial infarction (MI). This presents a challenge in identifying
patients with MINS without proper surveillance and monitoring in place.
Objectives: The purpose of this study is to improve anesthesia provider knowledge on the value
of perioperative troponin monitoring in identifying myocardial injury after noncardiac surgery.
A literature review including primary research studies addresses the PICO question: “In patients
older than 45 years of age with cardiovascular risk factors, does routine perioperative troponin
monitoring vs. monitoring traditional subjective symptoms indicative of postoperative
myocardial ischemia improve identification of myocardial injury after noncardiac surgery?” The
literature review is used to provide the educational framework to improve provider knowledge.
The overall objective is to increase awareness with the intention of improving healthcare
outcomes for surgical patients.
Methodology: The primary methodology of the proposed project is to administer an online
educational intervention to providers which focuses on the benefits of perioperative troponin
monitoring in the early identification of MINS. Pre- and post-assessment surveys will be used to
measure improvement of provider knowledge before and after the intervention.
Results: Overall, there was an improvement in provider knowledge following the education
intervention. Additionally, the likelihood of utilizing perioperative troponin monitoring increased
among providers.
Conclusions: Currently, troponin monitoring is not standard practice in high-risk patients
undergoing major noncardiac surgery. The educational intervention provided was effective in
improving anesthesia provider knowledge of MINS and the likelihood of utilizing perioperative
troponin monitoring. Increasing awareness of myocardial injury after noncardiac surgery and the
role of serial troponin monitoring can reduce mortality and improve postoperative outcomes.
Keywords: myocardial injury, noncardiac surgery, postoperative troponin elevations, cardiac
enzymes, postoperative mortality
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Introduction
Description of the Problem
The United States population continues to shift towards an older demographic and an
increasing number of patients are presenting for surgery with cardiovascular risk factors.
Coronary heart disease is currently the number one cause of death worldwide and is frequently
seen in patients presenting for noncardiac surgery. This presents a major concern when currently
one-third of major perioperative complications are attributed to cardiovascular events.1 Extensive
research has been conducted on the incidence of myocardial injury after non-cardiac surgery
(MINS), unfortunately myocardial infarction (MI) and MINS still account for significant
morbidity and mortality in the 30 days following noncardiac surgery.1 MINS is often an
unrecognized asymptomatic event which may be detected early through appropriate monitoring.
Early detection can lead to better outcomes; thus, importance of monitoring postoperative
troponin levels is gaining widespread recognition.
Over 300 million patients have surgery annually and perioperative death is the third
leading cause of death in the United States.2 Myocardial injury after noncardiac surgery is
considered a common perioperative complication present in up to 25% of patients healing from
noncardiac surgery and is associated with both short and long-term implications.3 MINS is
associated with increased morbidity, longer hospitalization, and in-hospital mortality, posing a
significant burden to the healthcare system.4 Cardiovascular complications currently account for
approximately 25% of 30-day hospital readmissions following surgery in patients who sustain
perioperative myocardial ischemia.4 In-hospital cardiovascular complications following
noncardiac surgery are associated with a 155% increase in adjusted expenditure compared with
noncardiac surgical admissions with minor complications.5 Proper screening and early
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intervention are essential to reducing overall healthcare costs. It is imperative to implement
appropriate perioperative monitoring to improve surgical outcomes and reduce costs associated
with postoperative complications.
The American College of Cardiology (ACC) and American Heart Association (AHA)
published a clinical practice guideline on the perioperative evaluation and management of
patient’s undergoing noncardiac surgery. This guideline consists of evidence-based proposals to
systematically improve cardiovascular health in perioperative patients having surgery.6 A
preoperative assessment is of vital importance in identifying those patients with a greater
likelihood of cardiovascular events so surgical and anesthetic management may be tailored to
optimize patient outcomes. Algorithms have been established to assist with perioperative risk
stratification. Assessment of functional capacity using metabolic equivalents (METS) and the
existence of cardiovascular risk factors using the revised cardiac risk index (RCRI) are
commonly employed when evaluating patients and determining the need for further testing prior
to surgery.2 Nevertheless, despite satisfactory preoperative risk stratification, patients still
present with MI and myocardial injury after surgery.7
The ACC/AHA recommendations currently question the usefulness of standard
perioperative troponin measurements, even in those patients deemed high-risk. This is attributed
to the lack of a specified management strategy for MINS.6 Measurement of troponin levels is
advised only when signs or symptoms indicative of myocardial ischemia or MI are present.6
Unfortunately, given the “silent ischemia” experienced by a large percentage of patients with
MINS, routine postoperative troponin screening is the only reliable way to detect myocardial
injury after noncardiac surgery.3 Recently, a growing body of evidence-based research is
challenging current guidelines, advocating for the use of perioperative troponin monitoring.
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Background and Pathophysiology
MINS is described as myocardial injury due to ischemia in the postoperative period
unrelated to a non-cardiac cause, such as sepsis or pulmonary embolism, and is strongly
associated with 30-day mortality.8,9,10 Patients who sustain MINS are predominantly
asymptomatic and do not meet the conventional definition and diagnostic criteria for myocardial
infarction (MI).8 This presents a challenge in identifying patients with MINS despite its common
occurrence in the postoperative period. 80% of patients with MINS may go unrecognized
without proper surveillance and monitoring in place.8
The pathophysiology of MINS in surgical patients describes a non-ST-elevation type
ischemia attributable to a prolonged imbalance between myocardial oxygen supply and
demand.11 This differs from classic ST-elevation MI (STEMI) related to an atherosclerotic event
and plaque rupture and is more likely to randomly occur during the weeks following surgery.1,7
Patients undergoing surgery have an elevated stress response and are prone to acute blood loss,
pain, hemodynamic instability, and hypercoagulability in the perioperative period, leaving them
vulnerable to ischemic events.1 These factors are thought to account for MINS and its common
presentation within the first three days after surgery.1,3 Patients at higher risk of MINS include
those ³ 45 years of age with cardiovascular risk factors and those ³ 65 years of age.3
Additionally, atrial fibrillation, diabetes, hypertension, congestive heart failure (CHF), peripheral
vascular disease, renal insufficiency, and urgent or emergency surgery have been identified as
independent predictors of MINS.
Purpose of the Study
The purpose of this study is to assess anesthesia provider knowledge on
myocardial injury after noncardiac surgery and the role of perioperative troponin monitoring. An
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educational intervention will be provided to certified registered nurse anesthetists as part of a
quality improvement project. The goal is to improve provider knowledge and the likelihood of
utilizing serial troponin monitoring in individuals considered high risk for myocardial injury
after noncardiac surgery. An increased understanding of the role of perioperative troponin
monitoring in high-risk adult patients undergoing noncardiac surgery may help in the early
identification of MINS and potentially reduce the risk of cardiovascular events following
surgery. The overall objective is to increase awareness with the intention of improving healthcare
outcomes for surgical patients.
Literature Review
Purpose of the Literature Review
Perioperative evaluation of cardiac biomarkers such as troponin and natriuretic peptides
strongly predict the occurrence of major adverse cardiovascular events (MACE) after surgery
including death, non-fatal cardiac arrest, congestive heart failure (CHF), and stroke.2 Elevated
troponin levels in the postoperative period have been indicated as the most compelling predictor
of 30-day mortality after surgery and is associated with higher 30-day rates of MACE.12
Identifying those patients at high risk for cardiovascular injury in the perioperative period and
careful monitoring of perioperative cardiac biomarkers is crucial in providing early intervention
and preventing death and disability.
The purpose of the literature review is to identify available evidence and evaluate
research findings on the value of perioperative troponin monitoring in identifying myocardial
injury after noncardiac surgery. The literature review includes primary research studies
answering the PICO question: “In patients older than 45 years of age with cardiovascular risk
factors, does routine perioperative troponin monitoring vs. monitoring traditional subjective
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symptoms indicative of postoperative myocardial ischemia improve identification of myocardial
injury after noncardiac surgery?” The results obtained from the literature review will be used to
formulate an educational intervention to improve anesthesia provider knowledge on myocardial
injury after noncardiac surgery and the role of perioperative troponin monitoring.
Methodology
Information Sources and Search Strategy
An online database search utilizing MEDLINE (ProQuest), Excerpta Medica Database
(EMBASE), and Cumulative Index of Nursing and Allied Health Literature (CINAHL) was
performed in pursuit of primary research studies. The terms used in the search were as follows:
perioperative OR postoperative, troponin OR cardiac enzyme OR biomarker, myocardial
ischemia OR myocardial injury OR cardiac complications. The search was limited to those
studies published since 2015 available in the English language. Studies were further filtered to
include only adults > 18 years of age. The MEDLINE database yielded 227 results, the CINAHL
database resulted in 84 articles, and the EMBASE database produced 285 articles. A total of 596
articles resulted from all 3 searches. After removal of duplicates, 367 articles were left to be
appraised.
Study Selection and Screening Method
The titles and abstracts of the remaining 367 articles were screened in relation to the
preliminary PICO question. The following inclusion criteria were applied:
1. Studies involving the specific monitoring of perioperative troponin levels
2. Studies that focused on the identification of myocardial injury after noncardiac surgery
and any subsequent outcomes
The following exclusion criteria were applied:
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1. Research reports that did not address primary research (e.g. opinion articles, editorials,
literature reviews)
2. Research reports involving cardiac surgery or procedures
3. Research reports involving assessment of other biomarkers (e.g. BNP)
4. Research reports focused on the prevention and/or treatment of MINS
5. Research reports solely focused on morbidity and mortality following MINS
Out of 367 articles a total of 23 articles were found to be relevant and underwent a full-text
screening process. Of these 23 articles, 8 articles were excluded. 1 article was excluded for being
an editorial, 4 articles were excluded because they focused on long-term outcomes and adverse
events associated with MINS, 1 article was excluded because it focused on the medical
management of MINS, and 2 articles were excluded because they did not specify how many
patients with MINS presented with clinical symptoms. Fifteen studies met the eligibility
requirements and were included in literature review. A PRISMA flow diagram is shown in
Figure 1 that provides a visual representation of the literature review screening process.
Data Collection and Analysis
The selected studies were evaluated using the John Hopkin’s Nursing Evidence-based
Practice process to determine the strength and quality of research. According to John Hopkin’s
strength of research evidence rating scheme, level I evidence comprising of evidence obtained
from an experimental study, randomized controlled trial, or systematic review of randomized
controlled trials, with or without meta-analysis, is considered the strongest level of evidence.13
Level II evidence includes evidence obtained from a quasi-experimental study or a systematic
review which includes quasi-experimental studies, with or without meta-analysis.13 Level III
evidence obtained from a quantitative non-experimental study (e.g., observational cohort study),
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Figure 1. PRISMA Flow Diagram
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Research evidence is further evaluated and determined to be of high quality, good quality, or
low-quality evidence. “High” quality evidence contains consistent and generalizable results, a
sufficient sample size, adequate control, definitive conclusions, and consistent recommendations
based on a thorough literature review established from scientific evidence.1 “Good” quality
evidence contains reasonably consistent results, a sufficient sample, some degree of control,
fairly definitive conclusions, and reasonably consistent recommendations based on a fairly
comprehensive literature review.13 “Low” quality evidence contains little evidence with
inconsistent results, an insufficient sample size, and lacks any definitive conclusions.13
The selected studies were also evaluated for relevant information consistent with the
purposes of the literature review and stated PICO question. The information obtained and
evaluated from each observational cohort study included: (1) the study design and method, (2)
sample size and characteristics, (3) sample setting, (4) troponin measurement tool and abnormal
threshold value, (5) results of the study, (6) associated risk factors for MINS, (7) limitations of
the study, and (8) study conclusions. A matrix table was created to summarize the characteristics
and findings from each study, and an evidence rating was assigned to each study based on John
Hopkin’s research evidence appraisal tool.
Results
Study Characteristics
The selected observational cohort studies had a combined total of 38,758 patients undergoing
noncardiac surgery and troponin surveillance. All studies were published between 2015 and
2020, reflecting the most current evidence available. All studies were published in English but
were representative of a large, international group of countries from North America, South
America, Europe, Africa, Asia, and Australia. The majority of the studies focused on adults older
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than 45 years of age. Troponin elevation was measured in the context of a diverse array of
noncardiac surgeries including orthopedic, vascular, major abdominal, spinal, thoracic, head and
neck procedures.
Definitions and Findings of Outcomes
There were three main outcomes evaluated for this literature review: the prevalence of
MINS, the incidence of perioperative MI, and patient risk factors associated with MINS. MINS
is characterized as an elevated postoperative troponin level with at least one value above the 99th
percentile upper reference limit resulting from myocardial ischemia without the requirement of
an ischemic feature (e.g. chest pain or significant ECG changes), and occurs within 30 days of
surgery.14 According to the Fourth Universal Definition of Myocardial Infarction, acute MI is
defined as acute myocardial injury with clinical evidence of myocardial ischemia including the
detection of at least one elevated troponin value above the 99th percentile upper reference limit
with at least one of the following characteristics: symptoms of myocardial ischemia (e.g. chest
pain), new ischemic ECG changes, development of pathological Q waves, imaging evidence of
new loss of viable myocardium or new regional wall motion abnormality consistent with
ischemic etiology, or identification of a coronary thrombus by angiography or autopsy.15
The selected studies focus on the use of perioperative troponin monitoring to identify
prognostically significant elevated troponin levels indicative of myocardial injury. Depending on
the type of troponin assay used, manufacturer-derived 99th percentile cutoffs were applied to
classify troponin results as positive or negative.
Prevalence of MINS. Based on this analysis, MINS was identified in 15-25% of patients
undergoing noncardiac surgery in 8 out of 15 studies.10,14,16-21 Five studies had an incidence of 515% and two studies identified MINS in 29-46% of patients.22-26 Duceppe et al and Thomas et al
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conducted studies in patients undergoing vascular surgery (primarily endovascular aortic repair,
open abdominal aortic aneurysm repair, and open lower limb perfusion) and reported higher rates
of troponin elevation compared to other studies.26,28 Three additional studies focused on vascular
surgery and reported troponin elevations in 15-25.5% of their patients, with many of these
patients not experiencing clinical ischemic symptoms or ECG changes.14,19-20 Coetzee and
colleagues reported the lowest incidence of MINS at 4.9% in their study of 301 patients
undergoing noncardiac surgery including intraabdominal, thoracic, joint replacement, major
orthopedic, and vascular surgery.22 Gorgun and colleagues reported a similar incidence of MINS
at 5%, but the study focused on patients having major colorectal surgery.24 Coetzee et al and
Gorgun et al were the only two studies that reported an incidence of MINS less than 10%.
Perioperative MI. The incidence of MI according to the Fourth Universal Definition of
Myocardial Infarction is less common, although still significant. Bass et al and Huang et al
reported a 5.5% incidence of MI in patients with elevated troponin who underwent orthopedic
and abdominal surgery.24,26 In a study performed by Brown and colleagues, MI was diagnosed in
11% of patients with MINS who had undergone either orthopedic or vascular surgery, of which
70% had no ischemic symptoms. Ekeloef et al reported a similar occurrence of MI in 11.2% of
patients diagnosed with MINS who had undergone major emergency abdominal surgery, and
none of these patients had any ischemic subjective symptoms. Devereaux et al conducted a study
representing a large sample size of over 21,000 patients which showed a higher incidence of MI,
reporting a frequency of 21.7% in patients diagnosed with MINS who primarily underwent
orthopedic and major general surgery.10 Additionally, 68% of these patients did not experience
any ischemic symptoms.10 Puelacher and colleagues reported a 29% incidence of MI in patients
with myocardial injury in a large cohort study involving a diverse group of surgeries including
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orthopedic, vascular, thoracic, visceral, urologic, spinal, and trauma surgery.27 82% of patients
with myocardial injury in this study did not exhibit any ischemic symptoms and chest pain was
present in only 6% of these patients.27 Biccard and colleagues observed patients specifically
undergoing vascular surgery and revealed a significant occurrence of MI, accounting for 42% of
patients who developed MINS.14 74% of patients diagnosed with MINS in this study exhibited
no clinical symptoms of ischemia.14 Grobben et al reported MI in 24% of carotid endarterectomy
patients exhibiting elevated troponin levels, with 75% of diagnosed MIs having no clinical
symptoms.19 Duceppe et al reported similar results in patients who underwent endovascular
aortic repair (EVAR), with 23.1% of patients with MINS meeting the clinical definition of MI. It
is worth noting, Puelacher and colleagues found mortality to be comparable in patients with
MINS who did not fulfill any other criteria for acute MI versus those who had at least one
additional criterion.27
Patient Risk Factors Associated with MINS. A number of risk factors have been
implicated in the development of myocardial injury after noncardiac surgery. Advancing age and
the presence of comorbidities such as cardiovascular disease, diabetes, and decreased renal
function pose the greatest risk for the development of MINS.
Age group. Age is considered a significant risk factor for MINS with older patients > 65
years of age more likely to have elevated postoperative troponin levels.10,14,16-21,23,24,26-28
Bass et al conducted a study on patients undergoing orthopedic surgery revealing an
increased risk for postoperative myocardial ischemia of 3.5-fold per decade of life.23 A
multivariate analysis performed in 4 other studies on all significant variables identified as
predictors of MINS through univariate analysis revealed a similar correlation between
increasing age and myocardial injury.17,24,26,28 Additionally, Gorgun and colleagues
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identified both age and elevated troponin concentrations as independent risk factors for
mortality following noncardiac surgery.24
Cardiovascular. Coronary artery disease (CAD), chronic heart failure (CHF), previous
history of MI, and atrial fibrillation have also been indicated as risk factors for the
development of MINS.14,16,18,20-21,25,27 In 5 studies, at least 30% of patients diagnosed with
MINS had CAD.14,24-27 Additionally, those with coronary artery disease are much more
likely to sustain myocardial infarction after surgery. Brown et al found 81% of those
diagnosed with postoperative MI to have a history of CAD.16 Duceppe and colleagues
also revealed MINS to be strongly associated with CHF, with CHF being present in
46.2% of EVAR patients who sustained myocardial injury.26 According to Biccard et al
and Puelacher et al, chronic heart failure and atrial fibrillation were both independent risk
factors for MINS, with P-values of 0.002 or less.14,27
Diabetes. Silent ischemia is known to occur with increased frequency in diabetic patients
and is thought to be due to cardiac autonomic neuropathy.29 Therefore, identifying
myocardial injury in these patients can be challenging without objective data. After
performing a multivariate analysis, Bass et al found that diabetes was an important
predictor of postoperative myocardial ischemia.23 According to this analysis, the odds of
sustaining myocardial injury increased 2.2-fold in patients with diabetes. Additionally,
MINS was found to be significantly associated with diabetes mellitus in three other
studies, with P-values of 0.002 or less.18,21,27
Renal function. Myocardial ischemia is a major cause of death in in patients with
chronic kidney disease (CKD) and CAD is also highly prevalent in this population.30
Therefore, CKD is considered a significant risk factor for MINS. According to Duceppe
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and colleagues, 45.5% of patients who sustained myocardial injury after undergoing
endovascular aortic repair had an eGFR < 60 mL/min, whereas only 27% of patients
without myocardial injury had an eGFR < 60 mL/min.25 Gorgun et al. found a GFR < 45
mL/min in 32.4% of patients with troponin elevation following carotid endarterectomy
compared to 11.6% of patients without troponin elevation.24 Brown and colleagues also
reported a higher incidence of CKD in patients who sustained myocardial infarction
following vascular and orthopedic surgery, and was present in 23% of those with MI.16
Risk of Bias
Selection bias was an issue due to incomplete and inconsistent data collection. In a
retrospective study conducted by Duceppe and colleagues, data was collected on patients with at
least one postoperative troponin level within three days after surgery.26 MINS could have been
missed in those patients who only had a single troponin level drawn compared to those who had
serial troponin measurements done. Likewise, Coetzee and colleagues performed a prospective
observational study where only 10% of patients had a second troponin level drawn within 72
hours of surgery.22 Monitoring serial troponins provides a trend of rising and falling values,
further increasing the probability of identifying myocardial injury. Five studies measured only
one troponin value or failed to measure serial troponins consistently. This could have resulted in
underestimating the incidence of myocardial injury after surgery. Furthermore, routine ECGs
were not performed in all patients with troponin elevation which could have also underestimated
the occurrence of perioperative MI.
Information bias refers to outcomes being misclassified or measured with error. A lack of
baseline troponin levels could have contributed to information bias. Baseline troponin levels
were not measured in 9 out of 15 studies, and 2 other studies did not measure baseline troponin
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levels in all patients. Thus, those patients with chronically elevated troponin levels could have
been misclassified as having MINS in the postoperative period. Baseline preoperative troponin
values help differentiate chronically elevated levels from acute myocardial damage and give a
more accurate identification of MINS.27-28
Reporting bias was another concern. Devereaux et al admitted to using arbitrary criteria
for prognostically important troponin elevation.10 Puelacher et al also used arbitrary delta values
to define myocardial injury.27 Without standardized thresholds, it is difficult to accurately
identify clinically significant myocardial injury.
Discussion
Summary of the Evidence
The asymptomatic nature of MINS is of clinical importance. It is important to identify
those individuals at risk for myocardial injury after noncardiac surgery so proper surveillance
measures may be implemented. Troponin elevations are a prognostic tool capable of identifying
patients with poor functional reserve who are at high risk for mortality due to underlying
comorbidities.24 All of the studies, with the exception of two, identified MINS in at least 10% of
patients following surgery. Patients who primarily underwent vascular surgery showed the
highest incidence of MINS with up to 42% of those diagnosed with MINS meeting the universal
definition for perioperative MI.14,26,28 The majority of these patients were asymptomatic and
otherwise would not have been identified without routine perioperative troponin monitoring.
Age is considered a significant risk factor for MINS. Individuals > 65 years of age have
an increased risk of both postoperative myocardial injury and death following noncardiac
surgery. Older individuals are also more likely to have comorbidities associated with diminished
cardiac reserve. Therefore, older individuals are more likely to benefit from routine perioperative
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troponin monitoring. Other significant risk factors include CAD, CHF, history of previous MI,
atrial fibrillation, diabetes, and chronic kidney disease.
Considering the high incidence of MINS in patients undergoing vascular surgery, it is
possible CAD is underdiagnosed in patients with peripheral vascular disease. Szczeklik et al
found CAD was not more prevalent in patients with critical limb ischemia (CLI) who sustained
myocardial injury compared to those who did not.20 This indicates the presence of CAD may be
underestimated in CLI patients.20 It would be prudent to treat these patients as if they have CAD,
whether or not they have been officially diagnosed, and institute troponin monitoring.
Limitations
The limitations to this literature review must be acknowledged. This review included
observational cohort studies and thus were not classified as the highest level of evidence. All of
the studies had defined inclusion and exclusion criteria, but such criteria were not consistent
among studies. Most of the studies included in this review were prospective in nature which
allowed for a more complete study design; however, four studies were classified as retrospective.
There is limited control over data collection in retrospective studies and data may be incomplete,
inaccurate, or inconsistently measured between subjects.31 This was certainly the case when
Duceppe et al. conducted a retrospective study where baseline troponin levels were not drawn,
serial troponin levels were not measured, and four different troponin assays were used.
Additionally, this review did not take into consideration intraoperative factors such as anesthetic
technique, intraoperative blood pressure or heart rate, blood loss, and transfusion events. Such
factors can also affect the incidence of MINS and may have affected the results in this review.
Cost Analysis
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It is important to consider the feasibility of perioperative troponin monitoring in terms of
the cost associated with it. While the cost of troponin monitoring itself is relatively inexpensive,
follow-up diagnostic tests and consultations in patients with elevated troponin must also be
considered. Buse et al reported an incremental cost of $112.18 CAD per screened patient with an
incremental cost per case of MINS detected ranging between $1134 CAD and $2138 CAD.9
Given the high incidence of MINS and poor prognosis of these patients, the cost associated with
postoperative complications would be far greater without timely identification. Mantha and
colleagues reported troponin surveillance to have an incremental cost-effectiveness ratio of
$12,641 per quality-adjusted life year (QALY) in patients presenting for open abdominal aortic
surgery, considering it a cost-effective measure when interpreted with a threshold value of
$50,000/QALY.32 The threshold of $50,000/QALY is often used for commonly funded
interventions and is frequently applied in decision analytic cost-effectiveness models related to
cardiovascular medicine.32 While both studies mentioned have their limitations, they both
support the role of perioperative troponin monitoring as a cost-effective measure.
Recommendations for Practice
Early identification of myocardial injury through routine troponin surveillance allows
appropriate interventions to take place, potentially reducing morbidity and mortality following
noncardiac surgery. Currently, troponin monitoring is not standard practice in high-risk patients
undergoing major noncardiac surgery. This is attributed to the lack of a specified management
strategy for MINS. Although there is no definitive treatment for MINS, there is promising
research suggesting the use of anticoagulants in the acute as well as long-term setting may
prevent major complications in patients who have sustained MINS.33 According to George et al,
the 30-day mortality rate was 11.7% in patients diagnosed with MINS compared to 2.5% of
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patients who did not have MINS.18 Mortality was reduced to 6.7% of patients with MINS who
received aspirin postoperatively.18 Furthermore, a large, international, randomized-controlled
study testing the efficacy of an oral direct thrombin inhibitor in patients diagnosed with MINS,
found that dabigatran reduced major vascular complications following surgery with no increased
risk of major bleeding.34
HMG-CoA reductase inhibitors, also known as statins, have also been correlated with
positive outcomes. In a study performed by Park and colleagues, a statin prescription at
discharge was found to be associated with improved mortality after MINS, with significant
reductions in 1-year and overall mortality in patients receiving statin therapy.35 The pleiotropic
effects of statins make them an attractive option in preventing perioperative cardiovascular
complications as they exert anti-inflammatory properties, increase nitric oxide bioavailability,
and promote plaque stabilization.36 As more research continues to be conducted on management
strategies for MINS, cardiac consultation in patients who have sustained MINS should be
strongly considered so that appropriate individualized therapy may be implemented. Given the
evidence suggesting that available treatments may reduce morbidity and mortality in patients
diagnosed with MINS, it would be prudent to routinely measure troponin levels on postoperative
days 1-3 in patients ³ 65 years old and/or with known risk factors such as CAD or diabetes.
Routine monitoring prevents missing an opportunity to provide beneficial intervention to highrisk individuals.
Recommendations for Future Research
Despite the heterogeneity in performed studies, extensive research has determined routine
troponin monitoring to be an effective method in identifying MINS in otherwise asymptomatic
patients. Furthermore, elevated troponin levels have been found to be strongly associated with
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increased morbidity and mortality following surgery. If any further research focuses on the value
of troponin levels in the identification of MINS, it should aim to more accurately assess troponin
elevations through consistent measurement of baseline troponin values and serial troponin levels
through postoperative day 3.
More importantly, more research should be conducted on management strategies for
MINS as this would provide the most benefit to patients and would further justify the value of
perioperative troponin monitoring. Ideally, such research would comprise of randomized
controlled trials to determine the true efficacy of proposed treatments. More studies focusing on
the cost-effectiveness of troponin monitoring and any subsequent treatments should also be
performed to gain a better understanding of the cost-benefit.
Methodology
Setting and Participants
To successfully achieve the goals of this quality improvement project, a series of actions
will be conducted that involve a specific group of study participants receiving an educational
intervention on perioperative troponin monitoring. The main setting of this quality improvement
project will take place at Memorial Regional Hospital in Hollywood, Florida. Primary
participants include all certified registered nurse anesthetists (CRNAs) employed with Envision
Physician Services. The participants will be recruited voluntarily, and the anticipated sample size
will be between 5-15 participants.
Description of Approach and Project Procedures
The primary methodology of the proposed project is to administer an online educational
intervention to providers which focuses on the benefits of perioperative troponin monitoring in
the early identification of MINS. Participants will initially complete an online preassessment test
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that gauges current knowledge and perceptions on perioperative troponin monitoring and MINS.
Participants will then watch a ten minute online educational module about myocardial injury
after noncardiac surgery and the role of perioperative troponin monitoring. Provider education is
important in bridging gaps in knowledge and is necessary to improve the quality of patient care
delivered and subsequent healthcare outcomes. The presentation will offer insight into the
background and pathophysiology of MINS, risk factors most associated with MINS, and the role
of perioperative troponin monitoring in identifying MINS. The final phase will involve an online
post-assessment test to evaluate knowledge gained and any changes in perception regarding
perioperative troponin monitoring.
The information obtained in the post-assessment survey will provide greater feedback
regarding the impact of the educational intervention and will determine how to best move
forward in expanding perioperative troponin monitoring in the identification of MINS. The
pre/post-testing provides relevant information regarding the effectiveness of the educational
intervention and seeks to promote the increased utilization of perioperative troponin monitoring
in high-risk patients undergoing noncardiac surgery. Results will also demonstrate if further
provider education is needed and if the program would be beneficial to other providers.
Protection of Human Subjects
For this study, the recruitment population will include certified registered nurse
anesthetists employed with Envision Physician Services who work at Memorial Regional
Hospital in Hollywood, Florida. This population is important because they directly provide care
to high-risk patients undergoing noncardiac surgery and thus would benefit from the education
provided as a means to improve patient outcomes following surgery. Recruitment will be
conducted via email invitation to all certified registered nurse anesthetists. Participation is
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voluntary and there is no penalty if participants decide to withdraw from the QI project. There
are no perceived risks to the study as it only requires the time spent by each participant in the
education intervention.
Data Collection
The primary instruments of data collection will include a pre-assessment and postassessment questionnaire to determine the effects of the education intervention. Both
assessments will be conducted using surveys consisting of approximately 10 questions focusing
on knowledge and practice using Qualtrics. In this manner, the pretest will gauge knowledge and
current perspectives on the educational material while the posttest survey will determine if the
participants gained knowledge from the intervention and will apply their knowledge to the
practice environment. The instrument reliability and validity will be measured in accordance
with the intervention provided and its effectiveness for the participants. The data collected will
be confidential and no subject identifiers will be recorded during any component of the study.
Data Management and Analysis Plan
The co-investigator for this project will be the DNP student who will be responsible for
administering the survey. To evaluate the responses provided on the pretest and posttest, Excel
software will be used to determine if participants received any knowledge and potentially modify
their practice in response to the educational tool. Each question will be measured, and the
responses recorded to identify the knowledge base before and after the intervention as well as the
practical applications of the intervention. Through statistical analysis, the study results will
identify patterns which will be used to determine the effectiveness of educational intervention
and its impact on clinician practice. The co-investigator will store the collected data in a
password protected laptop computer.
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Pre-Test Participant Demographics
The pretest demographics are shown in Table 1 below.
Table 1.
Pre-Test Participant Demographics
Demographics
Total Participants
Gender
Male
Female
Age
18 – 30 yr
31 – 40 yr
41 – 50 yr
51 – 60 yr
> 60 yr
Prefer Not to Say
Ethnicity
Hispanic
Caucasian
African American
Asian/Pacific-Islander
Other
Education
Masters
Doctorate
Years of CRNA Practice
0 – 2 yr
2 – 5 yr
5 – 10 yr
10 – 20 yr
> 20 yr

N (%)
10 (100%)
1 (10%)
9 (90%)
0 (0%)
5 (50%)
1 (10%)
2 (20%)
1 (10%)
1 (10%)
0 (0%)
7 (70%)
2 (20%)
0 (0%)
1 (10%)
7 (70%)
3 (30%
2 (20%)
3 (30%)
1 (10%
4 (40%)
0 (0%)
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There were 10 participants in the pretest demographics, but only 8 completed the study in
its entirety. Most of the participants were female (n=9, 90%), as opposed to male (n=1, 10%).
Half of the participants were between the ages of 31 – 40 years old (n=5, 50%), and the
remaining participants were as follows: 41 – 50 years old (n=1, 10%), 51 – 60 years old (n=2,
20%), and greater than 60 years old (n=1, 10%). One participant declined to answer and there
were no participants less than 30 years of age. The following ethnicities were represented:
Caucasian (n=7, 70%), African American (n=2, 20%), and other (n=1, 10%). There were no
participants of Hispanic or Asian/Pacific-Islander descent. Information was obtained about the
participant’s level of education, and it was found that the majority had a masters degree (n=7,
70%) and only a few had a doctorate degree (n=3, 30%). Participants were also questioned about
their years of practice as a certified registered anesthetist (CRNA) and a mix of experience was
found: 0 – 2 years (n=2, 20%), 2 – 5 years (n=3, 30%), 5 – 10 years (n=1, 10%), and 10 – 20
years (n=4, 40%).
Prior to beginning the pretest, study participants were also asked about any previous
education regarding MINS and perioperative troponin monitoring. Many participants declined
having any training in the past year about MINS (n=4, 40%). Of the remaining participants, two
claimed having one training in the past year (20%), one claimed having two trainings in the past
year (10%), and three participants did not know or remember how many trainings they attended
(30%). The participants who received prior training about MINS were then asked if they
received any information not related to perioperative troponin monitoring. Two participants
claim they only received information related to troponin monitoring in their training (33.33%).
The remaining claim that the content had a little information not related to troponin monitoring
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(n=2, 33.33%) or some information related to troponin monitoring (n=1, 16.67%), and one
participant did not answer (16.67%).
Pre-Test Knowledge About MINS
10 participants completed the pretest evaluating their current knowledge and perceptions
about MINS and perioperative troponin monitoring. More than half of the participants (60%) did
not know MINS most commonly presents within 3 days of surgery. Additionally, the vast
majority (80%) were not aware that up to 80% of patients with MINS may go unrecognized
without proper surveillance and monitoring in place. However, 100% of the participants knew
that a diagnosis of MINS does not require the presence of an ischemic feature such as chest pain
or ECG changes. Many participants (70%) also knew how the pathophysiology of MINS differs
from classic ST-elevation MI.
Knowledge about patient risks factors was lacking. Only 20% of participants knew that
diabetes, chronic kidney disease, and age > 65 years old were considered significant risk factors
for MINS and did consider smoking to be a significant risk factor. On the other hand, 100% of
participants were aware that blood loss, hemodynamic instability, and hypercoagulability are
commonly associated events in the perioperative period which predispose patients to myocardial
ischemia.
Knowledge about possible treatment options for MINS was mixed. Two participants
(20%) believed there were no treatment options available for MINS. 30% of participants
incorrectly identified ACE inhibitors as a treatment option for MINS, but 70% of participants
correctly identified oral direct thrombin inhibitors as a treatment option and 30% of participants
correctly identified HMG-CoA reductase inhibitors as a treatment option. Despite those that did
not identify HMG-CoA reductase inhibitors as a treatment option, 100% of participants
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understood the mechanisms by which this class of drugs could be beneficial in preventing
cardiovascular complications after a diagnosis of MINS.
Pre-Test Knowledge and Perspective of Perioperative Troponin Monitoring
60% of participants were aware troponin monitoring is not standard practice in high-risk
patients undergoing noncardiac surgery. Given the nature of the question provided, these
participants acknowledged MINS as a common event, perceived troponin monitoring to be
reliable in detecting MINS, and believed there was evidence correlating elevated troponin levels
with increased morbidity and mortality following surgery. However, the remaining 40% of the
participants either believed routine troponin monitoring was not a reliable way to detect
myocardial injury after noncardiac surgery (n=3, 30%) or believed there was no evidence
suggesting elevated troponin levels are associated with increased morbidity and mortality
following surgery (n=1, 10%).
As expected, most participants were indifferent or were unlikely to utilize serial troponin
monitoring in high-risk patients undergoing noncardiac surgery. Only one participant (10%) was
somewhat likely to utilize perioperative troponin monitoring. The majority were unlikely to
employ serial troponin monitoring with 40% of participants somewhat unlikely and 20% of
participants extremely unlikely to monitor troponin levels after surgery. The remaining 30% of
participants were neither likely nor unlikely to institute troponin monitoring.
Post-Test Participant Demographics
The posttest demographics are shown in Table 2 below.
Table 2.
Post-Test Participant Demographics
Demographics
Total Participants

N (%)
8 (100%)
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Gender
Male
Female
Age
18 – 30 yr
31 – 40 yr
41 – 50 yr
51 – 60 yr
> 60 yr
Prefer Not to Say
Ethnicity
Hispanic
Caucasian
African American
Asian/Pacific-Islander
Other
Education
Masters
Doctorate
Years of CRNA Practice
0 – 2 yr
2 – 5 yr
5 – 10 yr
10 – 20 yr
> 20 yr

29

0 (0%)
8 (100%)
0 (0%)
4 (50%)
0 (0%)
2 (25%)
1 (12.5%)
1 (12.5%)
0 (0%)
5 (62.5%)
2 (25%)
0 (0%)
1 (12.5%)
6 (75%)
2 (25%)
1 (12.5%)
3 (37.5%)
1 (12.5%)
3 (37.5%)
0 (0%)

There were 8 participants in the posttest demographics and all 8 actually completed the
study. 100% of the participants were female; no males completed the study.
Half of the participants were between the ages of 31 – 40 years old (n=4, 50%) and the
remaining participants were as follows: 51 – 60 years old (n=2, 25%) and greater than 60 years
old (n=1, 12.5%). One participant declined to answer; there were no participants less than 30
years of age or between the ages of 41-50 years old. The following ethnicities were represented:
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Caucasian (n=5, 62.5%), African American (n=2, 25%), and other (n=1, 12.5%). No participants
of Hispanic or Asian/Pacific-Islander descent participated. Information was obtained about the
participant’s level of education; the majority had a masters degree (n=6, 75%) and only a couple
had a doctorate degree (n=2, 25%). As far as years of practice as a certified registered nurse
anesthetist (CRNA): 0 – 2 years (n=1, 12.5%), 2 – 5 years (n=3, 37.5%), 5 – 10 years (n=1,
12.5%), and 10 – 20 years (n=3, 37.5%). Of note, although fewer people completed the posttest,
the distribution of the sample was similar across both tests.
Post-Test Knowledge About MINS
8 participants completed the posttest evaluating their knowledge and perceptions about
MINS and perioperative troponin monitoring after receiving the intervention. Half the
participants (n=4, 50%) still did not know MINS most commonly presents within 3 days
following surgery. Half of the participants (n=4, 50%) also did not know MINS may go
unrecognized in up to 80% of patients without proper surveillance and monitoring in place.
Following the intervention, less participants (87.5%) knew MINS does not require the presence
of an ischemic feature such as chest pain or EKG changes, and one participant (12.5%)
unexpectedly believed MINS to often not be asymptomatic despite the educational content
provided. However, a greater number of participants (87.5%) knew how the pathophysiology of
MINS differed from class ST-elevation MI.
Knowledge of patient risk factors increased significantly. Nearly all the participants
(87.5%) correctly identified patient risk factors for MINS as opposed to only 12.5% prior to the
intervention. Conversely, knowledge of perioperative risk factors such as blood loss,
hemodynamic instability, and hypercoagulability unexpectedly decreased from 100% to 75% of
participants.
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Increase in knowledge about the possible treatment options for MINS was insignificant.
Only 25% of participants could correctly identify the two possible treatment options following
the intervention. 5 participants (62.5%) could only partially identify treatment options for MINS,
similar to pretest results. Knowledge of HMG-CoA reductase inhibitors as a viable treatment
option did increase from 37.7% to 75%. However, knowledge of direct thrombin inhibitors as a
treatment option declined from 75% to 50%, 25% of participants incorrectly identified ACE
inhibitors as a treatment option, and one participant (12.5%) believed there were no treatment
options available despite education provided. Cognition of the mechanisms by which HMG-CoA
reductase inhibitors could prevent cardiovascular complications following a diagnosis of MINS
also decreased from 100% to 87.5% of participants.
Table 3.
Difference in Pre- and Post-Test Responses (Knowledge About MINS)
CORRECT RESPONSES
MYOCARDIAL INJURY AFTER NON-CARDIAC SURGERY
MOST COMMONLY PRESENTS WITHIN 3 DAYS
FOLLOWING SURGERY.
UP TO 80% OF PATIENTS WITH MINS MAY GO
UNRECOGNIZED WITHOUT PROPER SURVEILLANCE
AND MONITORING IN PLACE.
WHICH OF THE FOLLOWING IS NOT ASSOCIATED
WITH MINS? IT REQUIRES THE PRESENCE OF AN
ISCHEMIC FEATURE SUCH AS CHEST PAIN OR EKG
CHANGES.
WHICH OF THE FOLLOWING IS NOT CONSIDERED A
SIGNIFICANT RISK FACTOR FOR MINS? SMOKING.
HOW DOES THE PATHOPHYSIOLOGY OF MINS DIFFER
FROM CLASSIC ST-ELEVATION MI? MINS IS USUALLY
ATTRIBUTABLE TO A PROLONGED IMBALANCE
BETWEEN MYOCARDIAL OXYGEN DEMAND AND
SUPPLY.
WHICH OF THE FOLLOWING COMMONLY
ASSOCIATED EVENTS IN THE PERIOPERATIVE PERIOD
PREDISPOSE PATIENTS TO MYOCARDIAL ISCHEMIA?
ALL OF THE ABOVE: BLOOD LOSS, HEMODYNAMIC
INSTABILITY, AND HYPERCOAGULABILITY.

PRE-TEST

POST-TEST

DIFFERENCE

37.5%

50%

12.5%

12.5%

37.5%

25%

100%

87.5%

-12.5%

12.5%

87.5%

75%

62.5%

87.5%

25%

100%

75%

-25%
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POSSIBLE TREATMENT OPTIONS FOR MINS INCLUDE?
DIRECT THROMBIN INHBITORS AND HMG-COA
REDUCTASE INHIBITORS.
WHAT MAKES STATINS AN ATTRACTIVE OPTION IN
PREVENTING CARDIOVASCULAR COMPLICATIONS
AFTER A DIAGNOSIS OF MINS? ALL OF THE ABOVE:
ANTIINFLAMMATORY PROPERTIES, NITRIC OXIDE
BIOAVAILABILITY, AND PLAQUE STABILIZATION.

12.5%

25%

12.5%

100%

87.5%

-12.5%

Post-Test Knowledge and Perspective of Perioperative Troponin Monitoring
As expected, a greater number of participants (75%) were aware troponin monitoring is
not standard practice in high-risk patients undergoing noncardiac surgery. Given the nature of the
question provided, these participants acknowledged MINS as a common event, perceived
troponin monitoring to be reliable in detecting MINS, and believed there was evidence
correlating elevated troponin levels with increased morbidity and mortality following surgery.
The remaining 25% of the participants either believed routine troponin monitoring was not a
reliable way to detect MINS (n=1, 12.5%) or that MINS was not common event following
surgery (n=1, 12.5%) despite the education provided.
Table 4.
Difference in Pre- and Post-Test (Knowledge of Perioperative Troponin Monitoring)
CORRECT RESPONSE

PRE-TEST

POST-TEST

DIFFERENCE

CURRENTLY, TROPONIN MONITORING
IS NOT STANDARD PRACTICE IN HIGHRISK PATIENTS UNDERGOING
NONCARDIAC SURGERY.

50%

75%

25%

12.5%

0%

-12.5%

37.5%

12.5%

-25%

INCORRECT RESPONSE
THERE IS NO EVIDENCE SUGGESTING
ELEVATED TROPONIN LEVELS ARE
ASSOCIATED WITH INCREASED
MORBIDITY AND MORTALITY AFTER
SURGERY.
ROUTINE TROPONIN MONITORING IS
NOT A RELIABLE WAY TO DETECT
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MYOCARDIAL INJURY AFTER
NONCARDIAC SURGERY.
MINS IS NOT A COMMON EVENT
BECAUSE SURGERY DOES NOT IMPOSE
STRESS ON THE BODY, THEREFORE, IS
DOES NOT LEAVE THE PATIENT
VULNERABLE TO ISCHEMIC EVENTS.

0%

12.5%

12.5%

According to the data, there was a positive change in perspective regarding perioperative
troponin monitoring following the intervention. Two participants (25%) were somewhat likely to
utilize serial troponin monitoring in high-risk patients undergoing noncardiac surgery, as
opposed to no participants prior to the intervention. However, 62.5% of participants exhibited no
change in perspective and one participant (12.5%) exhibited a negative change in perspective.
Overall, 50% of participants were still either somewhat unlikely (n=3, 37.5%) or extremely
unlikely (n=1, 12.5%) to employ perioperative troponin monitoring, an improvement from
62.5% before educational intervention. Two participants (25%) remained indifferent and were
neither likely nor unlikely to utilize troponin monitoring.
Table 5.
Difference in Pre- and Post-Test (Perspective of Perioperative Troponin Monitoring)
HOW LIKELY ARE YOU TO UTILIZE SERIAL
TROPONIN MONITORING IN HIGH-RISK PATIENTS
UNDERGOING NONCARDIAC SURGERY?

PRE-TEST

POST-TEST

DIFFERENCE

EXTREMELY LIKELY

0%

0%

0%

SOMEWHAT LIKELY

0%

25%

25%

NEITHER LIKELY NOR UNLIKELY

37.5%

25%

-12.5%

SOMEWHAT UNLIKELY

50%

37.5%

-12.5%

EXTREMELY UNLIKELY

12.5%

12.5%

0%

Summary of Data
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Overall, the results show there was a gain in knowledge between pre- and post-test assessments.

INDIVIDUAL RESULTS

100%
80%
60%
40%
20%
0%
1

-20%

2

3
Pre-test

4
Post-test

5

6

7

8

Improvement

In general, pre-test assessments show an average score of 54% compared to an average score of
68% on post-test assessments. The overall average improvement between pre- and post-test
assessments was 14%. Only 5 out of the 8 participants (62.5%) who completed the study showed
an improvement in knowledge following the intervention with an average increase of 24.4%
between pre- and post-assessment scores. The remaining participants either had no change in
knowledge (n=2, 25%) or had a decrease in knowledge (n=1, 12.5%) despite the education
provided.
Out of the participants who showed improvement in knowledge between pre- and posttest assessments (n=5), one participant (20%) was more likely to utilize perioperative troponin
monitoring following the intervention. Two participants (40%) remained somewhat unlikely to
employ troponin monitoring, one participant (20%) remained neither likely or unlikely to employ
troponin monitoring, and one participant (20%) was less likely to employ troponin monitoring
after the intervention, despite improvement in knowledge.
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Discussion
Limitations
Limitations of the QI project include a small sample size. The survey was deployed to all
certified registered nurse anesthetists at Memorial Regional Hospital via email, but many chose
not to participate in the study. A larger sample size would have increased the strength and
reliability of the study. The delivery method of the study could have also limited the results as it
was done entirely online. Not all participants are self-directed learners, and it is possible that
participants may have completed the study in an environment not conducive to learning. A more
controlled, in-person setting could have have yielded more accurate results.
Future Implications for Advanced Nursing Practice
Early identification of myocardial injury through routine troponin surveillance allows
appropriate interventions to take place, potentially reducing morbidity and mortality following
noncardiac surgery. Currently, troponin monitoring is not standard practice in high-risk patients
undergoing major noncardiac surgery. The outcomes of this study are important in determining
strategies available to participants that will improve knowledge and potentially change practice
to improve patient outcomes in high-risk patients undergoing noncardiac surgery. According to
the data collected, the educational intervention provided was effective in increasing anesthesia
provider knowledge on perioperative troponin monitoring and MINS. Furthermore, there was an
increase in the likelihood of utilizing perioperative troponin monitoring in high-risk patients. The
results of this study can be applied to a wider audience of certified registered nurse anesthetists.
As research continues to be conducted on management strategies for MINS, increasing
awareness of myocardial injury after noncardiac surgery and the role of serial troponin
monitoring can reduce mortality and improve postoperative outcomes.
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Conclusion
MINS is a commonly unrecognized event following noncardiac surgery due to its
asymptomatic presentation. Without routine troponin monitoring in place, the majority of
patients with myocardial injury after noncardiac surgery would be missed. This has serious
consequences as MINS is associated with increased morbidity and mortality within 30 days of
surgery, resulting in significant utilization of healthcare resources. As patient demographics
continue to shift towards an aging population with an increasing number of comorbidities, it
would be prudent to monitor troponin levels in the perioperative period. Currently, troponin
monitoring is not standard practice in high-risk patients undergoing noncardiac surgery and there
is a lack of knowledge among certified registered nurse anesthetists regarding the value of
troponin monitoring in identifying MINS. Educational intervention can effectively increase
provider knowledge and the likelihood of utilizing perioperative troponin monitoring in high-risk
patients. Overall, increased awareness can help prevent cardiovascular events after surgery and
improve healthcare outcomes in surgical patients.
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Appendix B: QI Project Consent

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“An Educational Intervention on the Role of Perioperative Troponin Monitoring in Adult Patients
Undergoing Noncardiac Surgery.”
INTRODUCTION
You are being asked to participate in a quality improvement project. The goal of this project is to improve
anesthesia provider knowledge on the use of perioperative troponin monitoring in identifying myocardial
injury after noncardiac surgery (MINS), as well as improve recognition of associated risk factors that
predispose patients to the development of MINS. The overall objective of the program is to increase the
quality of healthcare delivery and improve healthcare outcomes for surgical patients undergoing
noncardiac surgery.
Your participation will require approximately 20 minutes of your time. You will be asked to complete a
pre-test questionnaire, which is expected to take approximately 5 minutes. You will then be asked to view
a short 10-minute educational presentation online. After watching the video, you will be asked to
complete the post-test questionnaire, which should take approximately 5 minutes.
There are no foreseeable risks for participating in this project. The records of this project will be kept
private and will be protected to the fullest extent provided by law. If in any sort of report we might
publish, we will not include any information that will make it possible to identify you as a participant.
Records will be stored securely, and only the project team will have access to the records.
There is no cost or payment to you for receiving the health education and/or for participating in this
project. Your participation in this project is completely voluntary. You are free to participate in the
project or withdraw your consent at any point during the project.
If you have any questions about the purpose, procedures, or any other issues relating to this quality
improvement project, you may contact Araceli Plancarte at 561-809-5105/aplan021@fiu.edu or Dr. Jorge
Valdes at 305-348-7729/jvalde@fiu.edu.
By clicking the button below, you acknowledge that your participation in the study is voluntary, you are
18 years of age, and that you are aware that you may choose to terminate your participation in the study at
any time and for any reason.
Please note that this survey will be best displayed on a laptop or desktop computer. Some features may be
less compatible for use on a mobile device.
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INTRODUCTION
The primary aim of this QI project is to improve provider knowledge on the use of
perioperative troponin monitoring in identifying myocardial injury after noncardiac surgery
(MINS) to reduce cardiovascular morbidity and mortality following surgery.

Please answer the questions below to the best of your ability. The questions are in multiple
choice format. These questions are meant to measure knowledge on the identification and
management MINS.
PERSONAL INFORMATION
1. Gender: Male

Female

Other

Caucasian

African American

2. Age: ______
3. Ethnicity:
Hispanic

4. Level of Education: Master’s

Asian Other

Doctorate

5. How many trainings (in any format: in person, online, WINK, class, BHU, etc.) have you
attended in the past year that focused on myocardial injury after noncardiac surgery?
None 1

2

3

More than 3

I don’t know/I

don’t remember
6. If you did attend a training, did it include content OTHER THAN perioperative troponin
monitoring?
N/A No

Yes, a little.

Yes, some of the content.

content.
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Pre-test and Post-test
QUESTIONNAIRE
1. Myocardial injury after noncardiac surgery most commonly presents within _____
following noncardiac surgery.
a. 6 hours
b. 3 days
c. 5 days
d. 10 days
2. Up to ____ of patients with MINS may go unrecognized without proper surveillance
and monitoring in place.
a. 2%
b. 5%
c. 25%
d. 80%
3. Which of the following is NOT associated with MINS?
a. Elevated troponin values
b. Increased 30-day mortality
c. It requires the presence of an ischemic feature such as chest pain or EKG changes
d. It is often asymptomatic
4. Which of the following is NOT considered a significant risk factor for MINS?
a. Smoking
b. Diabetes
c. Chronic kidney disease
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d. Age > 65 years
5. How does the pathophysiology of MINS differ from classic ST-elevation MI?
a. MINS is usually attributable to a prolonged imbalance between myocardial oxygen
supply and demand
b. MINS is usually related to an atherosclerotic event or plaque rupture
c. MINS usually occurs more than 30 days following surgery
d. There is no difference, they are exactly the same
6. Which of the following commonly associated events in the perioperative period
predispose patients to myocardial ischemia?
a. Blood loss
b. Hemodynamic instability
c. Hypercoagulability
d. All of the above
7. Which of the following is TRUE?
a. There is no evidence suggesting elevated troponin levels are associated with
increased morbidity and mortality following surgery
b. Currently troponin monitoring is not standard practice in high-risk patients
undergoing major noncardiac surgery
c. Routine troponin monitoring is not a reliable way to detect myocardial injury after
noncardiac surgery
d. MINS is not a common event because surgery does not impose stress on the body,
therefore, it does not leave patients vulnerable to ischemic events
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8. Select all that apply: Possible treatment options for MINS include
a. Oral direct thrombin inhibitors
b. ACE inhibitors
c. HMG-CoA reductase inhibitors
d. None of the above
9. What makes statins an attractive option in preventing cardiovascular complications
after a diagnosis of MINS?
a. It exerts anti-inflammatory properties
b. It increases nitric oxide bioavailability
c. It promotes plaque stabilization
d. All of the above
10. How likely are you to utilize serial troponin monitoring in high-risk patients
undergoing noncardiac surgery?
a. Highly likely
b. Somewhat likely
c. Unlikely
d. Highly unlikely
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Appendix D: Table 1. Overview of Literature Review Results

Author(s)
And Pub
Year

Design/
Method

Subject
Selection/
Final Sample
Size and Setting

Measurement
Tool/
Abnormal
Threshold

Results

Risk
Factors

Limitations

Level of
Quality

Conclusions

Bass et al.
(2015)

-Ancillary
prospective
observational
study to
ongoing RCT.
- Multi-center
study
- Samples
obtained on
postop day 2

394 hip or knee
arthroplasty
patients
> 65 years old.

- hsTnT from
Meso Scale
Discovery
(MSD)
>14 ng/dL

13.5% of
patients had
MINS.
0.77%
identified
clinically as
having MI.

- age
- Diabetes

-Small sample
size
-No baseline
troponin and
troponin levels
only measured
once
-ECG not
routinely
performed for
elevated troponin

Level III
Grade B

Patients at high
risk for ischemia,
such as diabetics
and the elderly,
may benefit from
postoperative
troponin
surveillance.

-Prospective
observational
cohort study
-Multi-center,
international
study
-Troponin
measured 6
and 12 hours
postop and
post op days 13.

-502 patients
> 45 years old
taken from
VISION study
who underwent
vascular surgery
between August
2007-January
2011

-Roche 4th
generation
Elecsys TnT
assay
>0.03 ng/mL

-19% of
patients
developed
MINS. 74%
were
asymptomatic.
42% fulfilled
universal
definition of
MI.
-12.5%
mortality rate in
MINS patients
within 30 days
of surgery.

- age
-Atrial
fibrillation
-CHF
-CAD
-Renal
dysfunction
-Higher
mean
preoperative
heart rate

-No baseline
troponin

Level III
Grade B

Troponin
surveillance
detects MINS in
approximately
20% of patients
having vascular
surgery and MINS
is independently
associated with
30-day mortality.

Biccard et
al.
(2018)
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Brown et
al.
(2017)

-Ancillary
prospective
observational
study to the
VINO Trial (a
doubleblinded,
randomized
RCT)
-Single-center
study
-Troponin
measured
before surgery,
at the end of
surgery, and
postoperative
days 1-3 or
until
discharge.

-605 patients
predominantly
undergoing
vascular and
orthopedic
surgery.
-Mean age of 65 ±
11

-Roche
Elecsys 2010
hsc-TnT
(men: ≥14.5
ng/dL, women:
≥ 10 ng/dL, or
>50%
postoperative
hscTnT rise
from baseline)
-Siemen
Dimension
RxL cTnI
(0.07 ug/L)
-Both assays
were used to
compare
detection rates

Coetzee et
al.
(2018)

-Prospective
observational
single-center
cohort study
-Troponin
analyzed
within 24
hours after
surgery. 10%
of patients had
2nd level drawn
within 72
hours after
surgery.

-301 patients ≥
45 years old
undergoing
intrabdominal,
noncardiac
thoracic, joint
replacement,
major orthopedic,
and vascular
surgery.
- Groote Schuur
Hospital in South
Africa from
November 2014
to February 2016

-Roche 5th
generation hscTnT assay
≥33 ng/L

-22.2% of
patients had
MINS. 11% of
patients were
diagnosed with
MI of which
70% had no
symptoms.
-6-month
mortality was
increased 3 to
5-fold when
patients
experienced a
postoperative
hscTnT
increase.
-hs-cTnT
increased
detection of
postoperative
myocardial
injury when
compared to
cTnI.
Incidence of
MINS was
4.9%
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-CAD
-Kidney
disease
-Heart
failure
-Previous MI
-History of
CABG/PCI

-Single center
study
-Absolute or
relative change
metrics are
arbitrary.

Level III
Grade B

hscTnT assay
improves
incidence rate of
diagnosed
perioperative MI
compared to cTnI
assay by about a
2-fold increase.

There was
inadequate
data to
perform
multivariate
regression
analysis to
investigate
associations
between risk
factors and
MINS.

-Single center
study
-Small sample
size
-No baseline
troponin
-Not all patients
had 2nd level
drawn (MINS
may have been
missed)

Level III
Grade B

Data suggests
postoperative
troponin
surveillance is
necessary in
elevated risk
noncardiac
surgical patients
in South Africa.
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Devereaux
et al.
(2017)

-Prospective
observational
cohort study
-International,
multi-center
study
-Troponin was
measured 6-12
hours
postoperativel
y and on days
1,2, and 3 after
surgery.
-ECG for 
troponin
- 30 day
follow-up

-Over 21,000
patients ≥ 45
years old
undergoing
noncardiac
surgery (primarily
orthopedic and
major general)
from October
2008-November
2013

-Roche 5th
generation
Elecsys hsTnT
assay
≥14 ng/dL

-18% of
patients had
MINS. 21.7%
of MINS
patients were
diagnosed with
MI of whom
68% of patients
did not
experience any
ischemic
symptoms.
-
cardiovascular
complications
within 30 days
of surgery with
hsTnT ≥
20 ng/dL.

-Not
specified

-Baseline
troponin done in
only 40.4% of
patients
-Arbitrary
criteria for
prognostically
important hsTnT
elevation.

Level III
Grade B

Data supports that
MINS does not
require the
presence of an
ischemic feature
and elevated
postoperative
troponin levels
with and without
an ischemic
feature were both
associated with
increased risk of
30-day mortality.

Duceppe et
al.
(2019)

-Retrospective
observational
cohort study
-Data collected
from medical
records from
patients with at
least one
postoperative
troponin level
within 3 days
after surgery

267 patients ≥18
years old
undergoing
EVAR in two
tertiary care
centers in Canada
and Poland.

-Ultrasensitivity
troponin I
Vidas ≥19
ng/L
-non-high
sensitivity
troponin I
Vidas ≥0.01
ug/L
-hsTnT ≥20
ng/L
-non-hsTnT
≥0.03 ng/mL

-Myocardial
injury occurred
in 29.2% of
patients of
which 23.1%
met the
Universal
Definition of
MI.
-The majority
of patients with
MI did not
experience
ischemic
symptoms or
ECG changes.

- age
-RCRI score
≥3
-ASA 4
status
-Duration of
surgery
Perioperative
drop in
hemoglobin

-Retrospective
study
-No baseline
troponin
-Serial troponin
measurements
not done
-Different types
of troponin
assays used

Level III
Grade B

Majority of
patients with
myocardial injury
do not experience
any symptoms
and thus would be
missed without
routine troponin
monitoring.
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Ekeloef et
al.
(2020)

George et
al.
(2018)

-Retrospective
single center
observational
cohort study
-Data collected
from medical
records.
-Troponin was
measured daily
on
postoperative
days 1-3 as
part of
standard
protocol in
hospital.
-ECG if ≥45
ng/L

401 patients ≥18
years old who
underwent major
emergency
abdominal
surgery in
Zealand
University
Hospital between
February 2017
and January 2019.

-Siemens
Healthcare
Dimension
Vista cTnI
assay
≥45 ng/L

-Prospective
single center
observational
cohort study
-Troponin
measured at 12
and 24 hours
after surgery,
and 48 hours
postoperativel
y if clinically
indicated
-ECG
performed
-30 day
follow-up

-1075 patients ≥
45 years old with
at least one
comorbidity
(diabetes, HTN,
CAD, CVA, PVD)
and ≥ 65 years
old w/ or w/o
comorbidities.
Chronic renal
failure excluded.
- Elective
noncardiac
surgery
- Amerita
Institute of
Medical Sciences
in India 20152016.

-ARCHITECT
stat hs-TnI
assay (Abbott)
≥ 0.03 ng/dL

-24.4% of
patients had
MINS within
3rd
postoperative
day.
-11.2% of
MINS had an
in-hospital MI
and none of
these patients
had any
ischemic
subjective
symptoms

-* age
-RCRI score
≥2
-HTN
-Previous MI

-MINS was
diagnosed in
17.5% of
patients. 67% of
these patients
did not have
ECG changes.
-11.7% of
patients with
MINS expired
compared to
2.5% of patients
without MINS
-Mortality was
reduced in
patients who
received
postoperative
aspirin.

- age
-*Diabetes
-*CAD
-History of
CVA
-*Peripheral
nerve block
anesthesia
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-Retrospective
study
-Single center
study
-No baseline
troponin

Level III
Grade B

Monitoring
troponin levels
after major
emergency
abdominal
surgery can
identify patients at
high risk of
postoperative
mortality and
could potentially
improve risk
stratification after
surgery.

-No baseline
troponin
-Single center
study

Level III
Grade B

Use of standard
criteria for MI
alone would have
missed the
diagnosis of
prognostically
relevant
myocardial injury
in 67% of
patients. This
supports the need
to implement a
screening
protocol for
MINS.

*Confirmed
by
multivariate
analysis

*Confirmed
by
multivariate
analysis
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Gorgun et
al.
(2016)

Grobben et
al.
(2016)

-Prospective
observational
cohort study
-Troponin
measured
within 24 and
48 hours after
surgery
- ECG if
troponin >
0.01 ng/mL
-Follow-up at
30 days and 1
year

-1020 patients >
45 years old
undergoing major
colorectal
surgery.

-Retrospective
observational
cohort study
-Data obtained
from medical
records
-All patients
had routine
troponin levels
drawn on
postoperative
days 1,2, and 3
-30 day and 1
year follow-up

225 patients ≥ 60
years old
undergoing CEA
performed under
general
anesthesia.
Patients
undergoing CEA
combined with
cardiac surgery
were excluded.

-Roche 4th
generation
troponin T
assay
> 0.01 ng/mL

-5% of patients
had MINS with
only 16%
exhibiting
symptoms
-6% of MINS
patients were
diagnosed with
MI
-20% of MINS
patients expired
within 1 year
with 70% of
mortalities
occurring in
troponin
concentrations
≥ 0.03 ng/mL

- age
-Male
-CAD
-Diabetes
-Renal
insufficiency
-ASA 4
status
-Cancer

-Single center
study
-No baseline
troponin

Level III
Grade B

Troponin
elevation may not
only be an
indicator of
cardiac or
vascular
complications, but
rather an indicator
for all-cause
mortality. It can
identify patients
with poor
functional reserve
who are at high
mortality risk due
to underlying
medical
comorbidities.

-3rd generation
AccuTnI assay
> 60 ng/L

-15% had 
postoperative
troponin
-NSTEMI
diagnosed in
24% of patients
with troponin
elevation
-75% of
diagnosed MIs
were silent
-MACE
occurred in
29% of patients
with elevated
troponin vs. 6%
without

-  age
-Renal
failure
-Stroke as
clinical
indication of
CEA
-Type of
closure

-Retrospective
study
-Single center
study
-No baseline
troponin

Level III
Grade B

Troponin
elevation after
CEA occurred in
1 in 6 patients and
troponin elevation
was associated
with higher
incidence of
major adverse
cardiovascular
events.

-Single tertiary
institution from
March 2015 to
January 2016.

Tertiary referral
center between
January 2011 and
December 2013.
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Huang et
al.
(2018)

Puelacher
et al.
(2018)

-Retrospective
observational
cohort study
-Data obtained
from medical
records
-Troponin
levels were not
routinely
performed for
all patients,
only for
patients who
had identified
risk factors,
intraoperative
events, or
symptoms and
events after
surgery.
-Prospective
observational
cohort study
-Troponin
measured
before surgery
and on postop
days 1 and 2
-ECG for
elevated
troponin levels

-285 patients ≥
65 years old
undergoing
abdominal
surgery longer
than 2 hours.

-Roche
electrochemiluminesc
ent troponin I
assay
≥ 0.04 ng/mL

-12.6% with
troponin
elevation
-0.7% of total
patient
diagnosed with
MI

-National Center
of Gerontology in
Beijing, China
between January
2016 and March
2017.

-2018 patients
undergoing
noncardiac
surgery (visceral,
orthopedic,
trauma, vascular,
urologic, spinal,
and thoracic) ≥
than 65 years old
or ≥ 45 years old
with history of
CAD, PAD, or
stroke.
-University
Hospital in Basel,
Switzerland in
October 2014.

-CAD
-Infection
before
surgery
-blood loss >
800 mL
-non-venous
maintain
-nonlaparoscopic
surgery

-Retrospective
study
-Single center
study
-Troponin levels
not routinely
collected for all
patients

Level III
Grade B

Myocardial injury
is common in
elderly patients
undergoing
abdominal
surgery. Troponin
elevation in
elderly patients,
especially within
the first 7 days
after surgery may
aid in the risk
stratification and
prognostic
assessment.

-Single center
-Arbitrary delta
values used to
define
myocardial
injury

Level III
Grade B

MINS is common
after noncardiac
surgery and is
associated with
substantial shortand long-term
mortality.
Mortality is
comparable in
patients with
MINS not
fulfilling any
other additional
criteria required
for spontaneous
AMI versus those
with at least 1
additional
criterion.

*Confirmed
by
multivariate
analysis

-Roche
Elecsys hsTnT
assay
≥14 ng/L
increase above
preoperative
levels

-13.4% of
patients had
MINS and 82%
of these patients
did not show
any ischemic
symptoms and
chest pain was
only present in
6%
-29% of
patients with
MINS fulfilled
criteria for MI
-30 day
mortality  6fold with
MINS.
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- age

-CAD
-Previous MI
-CHF
-Atrial
fibrillation
-Valvular
heart
disease
-PAD
-Diabetes
-HTN
- RCRI
score
-nonelective
surgery
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Szczeklik
et al.
(2017)

Thomas et
al.
(2016)

-Prospective
observational
cohort study
-ECG and
troponin on
admission
-Additional
troponin levels
measured 3-6
hours after
surgery and
following
morning.
-ECG repeated
for elevated
troponin.

-239 patients ≥45
years old
undergoing
endovascular
revascularization.

-Prospective
observational
ancillary study
to an RCT.
-Troponin
samples were
drawn for all
patients
preoperatively
and at 6, 12,
24, and 48
hours postop.

-85 patients
undergoing major
vascular surgery
such as open
AAA repair, open
lower limb
perfusion, or
EVAR.
-Mean age: 74

-Roche
Elecsys hsTnT
assay
≥ 14 ng/dL

-Myocardial
injury in 25.5%
of patients.
Only 14.8% of
these patients
had any clinical
symptoms or
ECG changes.
-50% of all
patients who
died in 1st year
had myocardial
injury

- age
-CHF
-beta blocker
use
-  WBC
(infection?)
-¯ eGFR
-¯ Hgb
- baseline
CRP, BNP,
and hsTnT

-Single center
-a priori
specified
thresholds

Level III
Grade B

-Roche hsTnT
assay
≥ 14 ng/L

-46% of
patients had
significant
troponin
elevation
-5% of patients
were diagnosed
with MI
characterized
by chest pain or
ECG changes

- age
-ASA 3 or 4
-intraabdominal
vascular
surgery

-Small sample
size
-Mandatory ECG
monitoring was
not performed
for all patients
with elevated
troponin

Level III
Grade B

-Single center
study at
Jagiellonian
University
Hospital in
Krakow, Poland
between the
years of 20132015.
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Almost 25% of
critical limb
ischemia patients
have MINS after
endovascular
treatment.
Routine troponin
monitoring is
necessary in these
patients, as
opposed to
symptominitiated troponin
surveillance due
to only a minority
of patients
experiencing
clinical symptoms.
-High incidence
of myocardial
injury in vascular
patients
undergoing
surgery.
-A preoperative
hsTNT may be
useful so that each
patient has a
reference point to
calculate any
meaningful
increase, that way
an acute event can
be distinguished
from a chronic,
stable elevation.
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van Waes
et al.
(2016)

-Prospective
observational
cohort study
-Troponin was
measured daily
on the first 3
days after
surgery.
- 1 year
follow-up

-3,224 patients
aged ≥ 60 yrs of
age undergoing
intermediate to
high-risk
noncardiac
surgery
(intrabdominal,
intrathoracic,
suprainguinal
vascular surgery,
and emergency
surgery)
- University
Medical Center in
Utrecht, The
Netherlands
between January
2011 and
December 2012.

-3rd generation
AccuTnI assay
> 0.06 ug/L

-22% of
patients had
MINS
-MI occurred in
14% of patients
with MINS
-26% of
patients with
MINS died
within 1 year of
surgery
compared to
13% of patients
without MINS.
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- age
-Previous MI
-Heart
failure
-Renal
failure
-PVD
- ASA
Status
-Emergency
surgery

-No baseline
troponin

Level III
Grade B

Myocardial injury
as detected by
routine troponin
measurements is
associated with 1year mortality.
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Appendix E: QI Educational Module

An Educational Intervention
on the Role of Perioperative
Troponin Monitoring in
Adult Patients Undergoing
Noncardiac Surgery
By: Araceli Plancarte, RN
Jorge Valdes, DNP, CRNA, APRN

• Understand the background and pathophysiology of
myocardial injury after noncardiac surgery (MINS)
• Identify risk factors most commonly associated with
MINS
• Acknowledge the role of perioperative troponin
monitoring in identifying MINS

Objectives

Background of Problem
Myocardial injury after noncardiac surgery (MINS) is described as myocardial injury due to ischemia
in the postoperative period unrelated to a noncardiac cause, such as sepsis or pulmonary embolism.
MINS is a common perioperative complication present in up to 25% of patients healing from
noncardiac surgery and is associated with both long-term and short-term implications.
MINS is associated with increased morbidity, longer hospitalization, and 30-day mortality.
The asymptomatic nature of MINS presents a challenge in identifying patients despite its common
occurrence.
80% of patients with MINS may go unrecognized without proper surveillance and monitoring in place.
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Pathophysiology
Patients who sustain MINS are
predominantly asymptomatic and
do not meet the conventional
criteria for myocardial infarction
(MI).

Describes a non-ST elevation
type of ischemia attributable to a
prolonged imbalance between
myocardial oxygen supply and
demand.

Patients undergoing surgery
have an elevated stress
response and are prone to acute
blood loss, pain, hemodynamic
instability, and hypercoagulability
in the perioperative period,
leaving them vulnerable to
ischemic events.

Differs from classic ST-elevation
MI which is more likely to be due
to an atherosclerotic event and
plaque rupture.

These factors are thought to
account for MINS and its
common presentation within the
first three days after surgery.

Who is at risk for MINS?
• Age is considered a significant risk factor with with
older patients > 65 years of age at greatest risk
• History of CAD, CHF, previous history of MI, and atrial
fibrillation
• Diabetics have a 2.2-fold increased risk of sustaining
myocardial injury
• Patients with chronic kidney disease and eGFR < 60
mL/min
• High incidence of MINS in patients undergoing
vascular and urgent/emergent surgery compared to
other types of noncardiac surgery

Role of Perioperative
Troponin Monitoring
• Perioperative evaluation of cardiac
biomarkers such as troponin strongly
predict the occurrence of major adverse
cardiovascular events (MACE) after
surgery.
• Elevated troponin levels in the
postoperative period have been indicated
as the most compelling predictor of 30-day
mortality after surgery and is associated
with higher 30-day rates of MACE.
• Identifying those patients at high risk for
cardiovascular injury in the perioperative
period and careful monitoring of
perioperative cardiac biomarkers is crucial
in providing early intervention and
preventing death and disability.
This Photo by Unknown Author is licensed under CC BY-NC-ND
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Current Practice

• The ACC/AHA
recommendations currently
question the usefulness of
standard perioperative troponin
measurements, even in those
patients deemed high-risk.
• This is attributed to the lack of a
specified management strategy
for MINS.
• Currently, measurement of
troponin levels is advised only
when signs or symptoms
indicative of myocardial
ischemia or MI are present.
• Unfortunately, MINS is often
ASYMPTOMATIC.
• Routine postoperative troponin
screening is the only reliable
way to detect MINS.

Recommendations for Practice
A growing body of evidence-based research is challenging current guidelines, advocating for the use of perioperative
troponin monitoring.
Anticoagulants and HMG-CoA reductase inhibitors have been associated with reduced morbidity and mortality in patients
with MINS.
Given the evidence suggesting that available treatments may reduce morbidity and mortality in patients diagnosed with
MINS, it would be prudent to routinely measure troponin levels on postoperative days 1-3 in patients ≥ 65 years old
and/or with known risk factors such as CAD or diabetes.
As more research continues to be conducted on management strategies for MINS, cardiac consultation in patients who
have sustained MINS should be strongly considered so appropriate individualized therapy may be implemented.

Routine monitoring prevents a missed opportunity to provide beneficial intervention to high-risk individuals.

While the cost of troponin monitoring is relatively
inexpensive, follow-up diagnostic tests and
consultations in patients with elevated troponin must
also be considered.
However, given the high incidence of MINS and the
poor prognosis of these patients, the cost associated
with postoperative complications would be far greater
without timely identification.
Mantha and colleagues reported troponin surveillance
to have an incremental cost-effectiveness ratio of
$12,641 per quality-adjusted life year (QALY),
considering it a cost-effective measure when
interpreted against a threshold value of $50,000/QALY.
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Summary
• MINS is a common event following major noncardiac surgery, which often goes
unrecognized due to its asymptomatic presentation.
• MINS is associated with increased morbidity and mortality within 30 days of
surgery, resulting in significant utilization of healthcare resources.
• Routine postoperative troponin monitoring is the only reliable way to detect
myocardial injury after noncardiac surgery but is currently not standard practice.
• Defined management strategies for MINS continue to be researched, providing
support for the usefulness of troponin surveillance.
• Early identification of myocardial injury through routine troponin surveillance allows
appropriate interventions to take place, potentially reducing morbidity and mortality
following noncardiac surgery.
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